BPC-157 vs TB-500
BPC-157 and TB-500 are both recovery compounds evaluated on Vial: BPC-157 is ruo with preclinical evidence, and TB-500 is ruo with preclinical evidence, offered by 15 and 5 verified providers respectively.
Vial summary · compiled from public records
At a glance
Side by side
| Field | BPC-157 | TB-500 |
|---|---|---|
| Category | Recovery | Recovery |
| Brand names | — | — |
| FDA / legal status | RUO | RUO |
| Evidence tier | Preclinical | Preclinical |
| Administration route | Subcutaneous | Subcutaneous |
| Compounding access | RUO | RUO |
| Providers on Vial | 15 listed | 5 listed |
| Typical price band | $$ | $$ |
Verified providers offering each
Ranked by Vial Score, Vial’s 0 to 100 score built from federal and state public records. The score evaluates the provider, not the compound.
About each compound
About BPC-157
A synthetic 15-amino-acid peptide derived from human gastric juice proteins, BPC-157 (Body Protection Compound-157) demonstrates cytoprotective and regenerative properties in preclinical studies. Research in animal models suggests it may accelerate healing of tendons, ligaments, muscle, and gastrointestinal tissue through mechanisms involving angiogenesis, growth factor modulation, and nitric oxide pathway regulation. While extensively studied in rodent injury models, human clinical trial data remains limited, and the compound is not currently approved for therapeutic use by major regulatory agencies.
About TB-500
A synthetic peptide fragment derived from Thymosin Beta-4, this compound functions as an actin-sequestering protein that promotes cell migration, angiogenesis, and tissue repair. Its mechanism involves upregulating cell-building proteins and reducing inflammation at injury sites. Research applications have focused primarily on wound healing, cardiac tissue repair following ischemic injury, and musculoskeletal recovery in preclinical models.
Descriptions compiled from public FDA records and manufacturer labeling where available. Not medical advice.
This page evaluates compliance signals, not clinical outcomes. Consult a licensed physician before starting any therapy, medication, or treatment. Vial does not provide medical advice.